Emilov, B.; Sorokin, A.; Seiitov, M.; Kobayashi, B.T.; Chubakov, T.; Vesnin, S.; Popov, I.; Krylova, A.; Goryanin, I. Diagnostic of Patients with COVID-19 Pneumonia Using Passive Medical Microwave Radiometry (MWR). Diagnostics2023, 13, 2585.
Emilov, B.; Sorokin, A.; Seiitov, M.; Kobayashi, B.T.; Chubakov, T.; Vesnin, S.; Popov, I.; Krylova, A.; Goryanin, I. Diagnostic of Patients with COVID-19 Pneumonia Using Passive Medical Microwave Radiometry (MWR). Diagnostics 2023, 13, 2585.
Emilov, B.; Sorokin, A.; Seiitov, M.; Kobayashi, B.T.; Chubakov, T.; Vesnin, S.; Popov, I.; Krylova, A.; Goryanin, I. Diagnostic of Patients with COVID-19 Pneumonia Using Passive Medical Microwave Radiometry (MWR). Diagnostics2023, 13, 2585.
Emilov, B.; Sorokin, A.; Seiitov, M.; Kobayashi, B.T.; Chubakov, T.; Vesnin, S.; Popov, I.; Krylova, A.; Goryanin, I. Diagnostic of Patients with COVID-19 Pneumonia Using Passive Medical Microwave Radiometry (MWR). Diagnostics 2023, 13, 2585.
Abstract
Background.
Chest CT is widely regarded as a dependable imaging technique for detecting pneumonia in COVID-19 patients, but there is growing interest in microwave radiometry (MWR) of the lungs as a possible substitute for diagnosing lung involvement.
Aim.
The aim of the study is to examine the utility of the MWR approach as a screening tool for diagnosing pneumonia with complications in patients with COVID-19.
Methods.
Our study involved two groups of participants. The control group consisted of 50 individuals (24 male and 26 female) between the ages of 20 to 70 years who underwent clinical evaluations and had no known medical conditions. The main group included 142 participants (67 men and 75 women) between the ages of 20 to 87 years who were diagnosed with COVID-19 complicated by pneumonia and were admitted to the emergency department between June 2020 to June 2021. Skin and lung temperatures were measured at 14 points, including 2 additional reference points, using a previously established method. Lung temperature data were obtained with the MWR2020 (RTM-01-RES) (MMWR LTD, Edinburgh, UK), a CE Class I device. All participants underwent clinical evaluations, laboratory tests, chest CT scans, MWR of the lungs, and reverse transcriptase polymerase chain reaction (RT-PCR) testing for SARS-CoV-2.
Results.
The MWR exhibits a high predictive capacity as demonstrated by its sensitivity of 98.6% and specificity of 84.0%.
Conclusions.
MWR of the lungs can be a valuable substitute for chest CT in diagnosing pneumonia in patients with COVID-19, especially in situations where chest CT is unavailable or impractical.
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
